Cargando…

Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk

IL1-RN is an important anti-inflammatory cytokine that modulate the inflammation response by binding to IL1 receptors, and as a consequence inhibits the action of proinflammatory cytokines IL1α and IL1β. In this study, we hypothesise that sequence variants in the IL1-RN gene are associated with pros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lindmark, F, Zheng, S L, Wiklund, F, Bälter, K A, Sun, J, Chang, B, Hedelin, M, Clark, J, Johansson, J-E, Meyers, D A, Adami, H-O, Isaacs, W, Grönberg, H, Xu, J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2005
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361575/ https://www.ncbi.nlm.nih.gov/pubmed/16106254 http://dx.doi.org/10.1038/sj.bjc.6602729

Ejemplares similares

Polymorphisms in the CYP1B1 gene are associated with increased risk of prostate cancer
por: Chang, B L, et al.
Publicado: (2003)

Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci
por: Brown, W M, et al.
Publicado: (2004)

Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer
por: Merson, S, et al.
Publicado: (2014)

ATM haplotypes and breast cancer risk in Jewish high-risk women
por: Koren, M, et al.
Publicado: (2006)

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array
por: Saunders, Edward J, et al.
Publicado: (2016)

Mutation analysis of the MSMB gene in familial prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2010)

CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia
por: Tayeb, M T, et al.
Publicado: (2003)

Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
por: Suzuki, H, et al.
Publicado: (2008)

CHEK2 variants associate with hereditary prostate cancer
por: Seppälä, E H, et al.
Publicado: (2003)

Rapid progression of prostate cancer in men with a BRCA2 mutation
por: Narod, S A, et al.
Publicado: (2008)

Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections
por: Wambaugh, Morgan A, et al.
Publicado: (2020)

ATM polymorphisms as risk factors for prostate cancer development
por: Angèle, S, et al.
Publicado: (2004)

Genetic Determinants of Circulating Interleukin-1 Receptor Antagonist Levels and Their Association With Glycemic Traits
por: Herder, Christian, et al.
Publicado: (2014)

Polymorphism of the insulin gene is associated with increased prostate cancer risk
por: Ho, G Y F, et al.
Publicado: (2003)

An inherited NBN mutation is associated with poor prognosis prostate cancer
por: Cybulski, C, et al.
Publicado: (2013)

Organisms with alternative genetic codes resolve unassigned codons via mistranslation and ribosomal rescue
por: Ma, Natalie Jing, et al.
Publicado: (2018)

A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2009)

Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer
por: Edwards, S, et al.
Publicado: (2005)

Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y
por: Oder, Daniel, et al.
Publicado: (2016)

Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2
por: De Paola, F, et al.
Publicado: (2003)

Genetic architecture of prostate cancer in the Ashkenazi Jewish population
por: Vijai, J, et al.
Publicado: (2011)

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
por: Mikropoulos, Christos, et al.
Publicado: (2018)

HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease
por: Meitz, J C, et al.
Publicado: (2002)

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening
por: Pashayan, N, et al.
Publicado: (2011)

Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity
por: Robey, R W, et al.
Publicado: (2003)

The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer
por: Akbari, M R, et al.
Publicado: (2014)

A personalised approach to prostate cancer screening based on genotyping of risk founder alleles
por: Cybulski, C, et al.
Publicado: (2013)

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer
por: Nam, R K, et al.
Publicado: (2007)

The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas
por: Caldwell, G M, et al.
Publicado: (2006)

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
por: Edwards, S M, et al.
Publicado: (2010)

COX2 genetic variation, NSAIDs, and advanced prostate cancer risk
por: Cheng, I, et al.
Publicado: (2007)

Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes
por: Mühlbauer, K-R, et al.
Publicado: (2003)

Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene
por: Maier, C, et al.
Publicado: (2005)

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer
por: Agalliu, I, et al.
Publicado: (2007)

Splice variant PRKC-ζ(-PrC) is a novel biomarker of human prostate cancer
por: Yao, S, et al.
Publicado: (2012)

Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels
por: Jesser, C, et al.
Publicado: (2008)

Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families
por: Ray, A M, et al.
Publicado: (2009)

DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers
por: Ying, J, et al.
Publicado: (2009)

Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population
por: Nakazato, H, et al.
Publicado: (2003)

In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer
por: Perry, A S, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_7k952lmus0ksj0pk1qltd8f0cg